Investing in one of the leading pharmaceutical manufacturing companies.
This company, which employs researchers, scientists, and cutting-edge technology, produces a diverse range of medications. Their goal is to build a large pharmaceutical complex, starting with a serum production facility capable of producing 120 million units annually.

The company sources raw materials from reputable global manufacturers and strictly follows regulations such as cGMP, EP, USP, and BP, as well as WHO standards, to ensure the production of high-quality pharmaceuticals with proven clinical effectiveness. Specializing in 127 different drugs, this company is a key player in the industry.

In its initial phase, this company is concentrating on developing human electrolyte solutions, biological serums, and electrolyte-based supplements for veterinary use to enhance healthcare outcomes for humans and animals. The first phase involves an advanced serum production center on a 60,000 square meter site.

This initial phase is part of an ambitious project that aims to position the company as one of the largest pharmaceutical manufacturers. With a strong focus on innovation, quality, and meeting local healthcare needs, this pharmaceutical company is poised to make a significant impact in the pharmaceutical industry.